indexado en
  • Base de datos de revistas académicas
  • Abrir puerta J
  • Genamics JournalSeek
  • DiarioTOCs
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • cimago
  • Directorio de publicaciones periódicas de Ulrich
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Publón
  • miar
  • Comisión de Becas Universitarias
  • Fundación de Ginebra para la Educación e Investigación Médica
  • pub europeo
  • Google Académico
Comparte esta página

Abstracto

Human Papilloma Virus Vaccine in Indian Settings: Need of the Hour

Akanksha Rathi, Suneela Garg and GS Meena

Cervical cancer is a major public health challenge accounting for a fifth of the global incidence and mortality. India has a population of 432.20 million women aged 15 years and above who are at risk of developing cervical cancer. The factors leading to high prevalence of cervical cancer in India are many. The high mortality due to the disease is mainly due to lack of awareness and absence of organized screening programs. India needs to take a leaf out of the book of 58 countries that have included Human Papilloma Virus (HPV) vaccine in their national immunization schedule so that the prevalence of this cancer can be brought down. Simultaneously, a need of organized screening programs throughout the country cannot be ignored.